May 28, 2022 2:51 PM
BACK TO TOP
KSE100
42,861.45
319.74
(0.75%)
ALLSHR
29,257.53
230.68
(0.79%)
KSE30
16,276.12
133.09
(0.82%)
KMI30
69,055.39
597.56
(0.87%)
BKTi
11,870.79
30.79
(0.26%)
OGTi
10,735.28
97.75
(0.92%)
KMIALLSHR
21,000.61
185.67
(0.89%)
UPP9
11,123.70
81.65
(0.74%)
NITPGI
8,929.02
60.71
(0.68%)
NBPPGI
10,613.27
62.17
(0.59%)
MZNPI
8,676.95
62.21
(0.72%)
JSMFI
10,488.56
147.87
(1.43%)
ACI
8,265.60
74.83
(0.91%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.638.07
-3.93
(-0.61%)
1D
1M
6M
YTD
1Y
3Y
5Y
As of Fri, May 27, 2022 5:01 PM
REG
FUT
ODL
Open
642.00
High
642.00
Low
635.00
Volume
2,450
CIRCUIT BREAKER
593.85 — 690.15
DAY RANGE
635.00 — 642.00
52-WEEK RANGE
625.00 — 820.00
Ask Price
638.07
Ask Volume
200
Bid Price
0.00
Bid Volume
0
LDCP
642.00
VAR
15.00
HAIRCUT
30.00
P/E Ratio (TTM) **
10.47
1-Year Change *
-17.67%
YTD Change *
-11.07%

No record found

Open
645.00
High
645.00
Low
640.00
Close
640.00
Change
-0.31%
LDCP
642.00
Volume
14
Total Trades
6
CIRCUIT BREAKER
577.80 — 706.20
DAY RANGE
640.00 — 645.00
Ask Price
654.99
Ask Volume
49
Bid Price
630.11
Bid Volume
1
Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Mr. Syed Anis AhmedCEO
Mr. Ehsan Ali MalikChairman
Company Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Associates (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
62,467,245.70
Shares
97,900,302
Free Float
21,074,093
Free Float
21.53%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
May 6, 2022Transmission of Quarterly Report for the Period Ended March 31, 2022 View   PDF
Apr 28, 2022Financial Results for the Quarter ended March 31, 2022 View   PDF
Mar 29, 2022Transmission of Annual Report for the Year Ended December 31, 2021 View   PDF
Mar 24, 2022Transmission of Annual Report for the Year Ended December 31, 2021
REVOKED
View   PDF
Feb 24, 2022Financial Results for the Year Ended December 31, 2021 View   PDF
Oct 29, 2021Transmission of Quarterly Report for the Period Ended September 30, 2021 View   PDF
Oct 27, 2021Financial Results for the Quarter Ended September 30, 2021 View   PDF
Aug 27, 2021Transmission of Quarterly Report for the Period Ended June 30, 2021 View   PDF
Aug 27, 2021Financial Results for the Quarter Ended June 30, 2021 View   PDF
Apr 30, 2021Transmission of Quarterly Report for the Period Ended March 31, 2021 View   PDF
Apr 23, 2021Financial Results for the 1st Quarter Ended March 31, 2021 View   PDF
Mar 31, 2021Transmission of Annual Report for the Year Ended December 31st, 2020 View   PDF
DateTitleDocument
Apr 21, 2022Board Meeting View   PDF
Mar 29, 2022Notice of Annual General Meeting View   PDF
Feb 17, 2022Board Meeting View   PDF
Oct 21, 2021Board Meeting View   PDF
Aug 17, 2021Board Meeting View   PDF
Apr 22, 2021Certified Copy of Resolution passed at the 72nd Annual General Meeting View   PDF
Apr 16, 2021Board Meeting View   
Apr 6, 2021Board Meeting Other Than Financial Results View   PDF
Mar 29, 2021Notice of Annual General Meeting View   PDF
Feb 15, 2021Board Meeting View   PDF
Oct 20, 2020Board Meeting View   
DateTitleDocument
May 24, 2022Resignation of Company Secretary View   PDF
May 9, 2022Credit of Final Cash Dividend View   PDF
May 6, 2022Change of Chairman View   PDF
Mar 24, 2022Miscellaneous Information View   PDF
Dec 10, 2021Notice for Corporate Briefing Session View   PDF
Sep 23, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Sep 22, 2021Dispatch of Interim Cash Dividend View   PDF
Jun 4, 2021Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
May 4, 2021Credit of Final Cash Dividend View   
May 4, 2021Credit of Final Cash Dividend
REVOKED
View   
Mar 8, 2021Unusual Movement in price or volume of M/s Abbott Laboratories (Pakistan) Limited (ABOT) View   
Mar 8, 2021ABOT | Abbott Laboratories (Pakistan) Limited PDF
Dec 18, 2020Information under regulation No. 5.6.1(d) of PSX Rule Book View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2021202020192018
Sales42,569,85635,283,37730,155,87529,719,279
Profit after Taxation5,967,0574,535,2491,299,8852,694,333
EPS60.9546.3313.2827.52
Q1 2022Q3 2021Q2 2021Q1 2021
Sales11,771,15910,649,30610,907,1919,890,792
Profit after Taxation1,441,7791,209,9131,839,4971,442,492
EPS14.7312.3618.7914.73
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2021202020192018
Gross Profit Margin (%)37.7634.6428.2832.89
Net Profit Margin (%)14.0212.854.319.07
EPS Growth (%)31.56248.87(51.74)(35.93)
PEG0.370.07(0.66)(0.64)

Payouts

DateFinancial ResultsDetailsBook Closure
February 24, 2022 2:57 PM31/12/2021(YR) 200%(F) (D) 14/04/2022 - 21/04/2022
August 27, 2021 11:10 AM30/06/2021(YR) 200%(i) (D) 10/09/2021 - 17/09/2021
February 26, 2021 4:27 PM31/12/2020(YR) 250%(F) (D) 14/04/2021 - 21/04/2021
August 28, 2020 12:14 PM30/06/2020(HYR) 150% (i) (D) 09/09/2020 - 16/09/2020
March 2, 2020 3:11 PM31/12/2019(YR) 75%(F) (D) 20/05/2020 - 27/05/2020
February 21, 2019 3:04 PM31/12/2018(YR) 100%(F) (D) 16/04/2019 - 23/04/2019
August 17, 2018 3:07 PM30/06/2018(HYR) 100% (D) 04/09/2018 - 11/09/2018
February 26, 2018 3:36 PM31/12/2017(YR) 300% (D) 14/04/2018 - 23/04/2018
August 21, 2017 3:09 PM30/06/2017(HYR) 100% (D) 08/09/2017 - 15/09/2017
February 27, 2017 5:03 PM31/12/2016(YR) 300% (D) 11/04/2017 - 18/04/2017

Financial Reports